Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 142 articles:
HTML format



Single Articles


    July 2021
  1. STAQUICINI DI, Tang FHF, Markosian C, Yao VJ, et al
    Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  2. WANG Y, Yang C, Song Y, Coleman JR, et al
    Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  3. GOLDSTEIN JR, Cassidy T, Wachter KW
    Reply to Dushoff et al. and Pifarre i Arolas et al.: Age prioritization for COVID-19 vaccination does save lives and years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  4. AROLAS HPI, Acosta E, Myrskyla M
    Optimal vaccination age varies across countries.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  5. DUSHOFF J, Colijn C, Earn DJD, Bolker BM, et al
    Transmission dynamics are crucial to COVID-19 vaccination policy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  6. PETERSEN MB, Bor A, Jorgensen F, Lindholt MF, et al
    Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  7. TSCHERNE A, Schwarz JH, Rohde C, Kupke A, et al
    Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  8. SCHMELZ K, Bowles S
    Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  9. SATO-KANEKO F, Yao S, Lao FS, Nan J, et al
    Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  10. MCCARTHY KR, Von Holle TA, Sutherland LL, Oguin TH 3rd, et al
    Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  11. SIA ZR, He X, Zhang A, Ang JC, et al
    A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2021
  12. CHUMAKOV K, Avidan MS, Benn CS, Bertozzi SM, et al
    Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  13. MILKMAN KL, Patel MS, Gandhi L, Graci HN, et al
    A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  14. DONG C, Wang Y, Gonzalez GX, Ma Y, et al
    Intranasal vaccination with influenza HA/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  15. MAEDA DLNF, Tian D, Yu H, Dar N, et al
    Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  16. BUCKNER JH, Chowell G, Springborn MR
    Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  17. CASTRO MC, Singer B
    Prioritizing COVID-19 vaccination by age.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  18. KORN L, Bohm R, Betsch C
    Reply to Rabb et al.: Why promoting COVID-19 vaccines with community immunity is not a good strategy (yet).
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


    March 2021
  19. LU EY, Chen HH, Zhao H, Ozawa S, et al
    Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  20. BETSCH C, Korn L, Bohm R
    Reply to Weisel: From polarization to vaccination and back.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  21. WEISEL O
    Vaccination as a social contract: The case of COVID-19 and US political partisanship.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  22. LIU R, Americo JL, Cotter CA, Earl PL, et al
    One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  23. LU M, Dravid P, Zhang Y, Trivedi S, et al
    A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  24. GOLDSTEIN JR, Cassidy T, Wachter KW
    Vaccinating the oldest against COVID-19 saves both the most lives and most years of life.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  25. KAPLAN RM, Milstein A
    Influence of a COVID-19 vaccine's effectiveness and safety profile on vaccination acceptance.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  26. MADAN B, Zhang B, Xu K, Chao CW, et al
    Mutational fitness landscapes reveal genetic and structural improvement pathways for a vaccine-elicited HIV-1 broadly neutralizing antibody.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    February 2021
  27. BURTON DR
    A new lease on life for an HIV-neutralizing antibody class and vaccine target.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    


  28. SIT B, Fakoya B, Zhang T, Billings G, et al
    Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  29. ZHANG H, You X, Wang X, Cui L, et al
    Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  30. MURAKOWSKI DK, Barton JP, Peter L, Chandrashekar A, et al
    Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  31. HANNA CC, Ashhurst AS, Quan D, Maxwell JWC, et al
    Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  32. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
    Vaccinology in the post-COVID-19 era.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  33. PERSSON BD, John L, Rafie K, Strebl M, et al
    Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  34. GUEST JD, Wang R, Elkholy KH, Chagas A, et al
    Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  35. SU H, Liu Q, Bian X, Wang S, et al
    Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


  36. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    December 2020
  37. BOZHANOVA NG, Sangha AK, Sevy AM, Gilchuk P, et al
    Discovery of Marburg virus neutralizing antibodies from virus-naive human antibody repertoires using large-scale structural predictions.
    Proc Natl Acad Sci U S A. 2020;117:31142-31148.
    PubMed     Abstract available


    November 2020
  38. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed     Abstract available


  39. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed     Abstract available


  40. HENRIQUES P, Dello Iacono L, Gimeno A, Biolchi A, et al
    Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.
    Proc Natl Acad Sci U S A. 2020;117:29795-29802.
    PubMed     Abstract available


  41. GILBERT M, Sulikhan N, Uphyrkina O, Goncharuk M, et al
    Distemper, extinction, and vaccination of the Amur tiger.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2000153117.
    PubMed     Abstract available


  42. MASTERS NB, Eisenberg MC, Delamater PL, Kay M, et al
    Fine-scale spatial clustering of measles nonvaccination that increases outbreak potential is obscured by aggregated reporting data.
    Proc Natl Acad Sci U S A. 2020;117:28506-28514.
    PubMed     Abstract available


  43. DATTA R, Roy Chowdhury R, Manjunath K, Hanna LE, et al
    A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
    Proc Natl Acad Sci U S A. 2020 Nov 9. pii: 2010256117.
    PubMed     Abstract available


    October 2020
  44. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    PubMed    


  45. CHENG Q, Trangucci R, Nelson KN, Fu W, et al
    Prenatal and early-life exposure to the Great Chinese Famine increased the risk of tuberculosis in adulthood across two generations.
    Proc Natl Acad Sci U S A. 2020 Oct 19. pii: 2008336117.
    PubMed     Abstract available


  46. AFFANDI AJ, Grabowska J, Olesek K, Lopez Venegas M, et al
    Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes.
    Proc Natl Acad Sci U S A. 2020 Oct 16. pii: 2006186117.
    PubMed     Abstract available



  47. Correction for Escobar et al., BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2019438117.
    PubMed    


    September 2020
  48. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    PubMed    


  49. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    PubMed    


  50. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    PubMed    


  51. METRAS R, Edmunds WJ, Youssouffi C, Dommergues L, et al
    Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic.
    Proc Natl Acad Sci U S A. 2020;117:24567-24574.
    PubMed     Abstract available


  52. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    


  53. MICOLI F, Bjarnarson SP, Arcuri M, Aradottir Pind AA, et al
    Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.
    Proc Natl Acad Sci U S A. 2020 Sep 8. pii: 2005857117.
    PubMed     Abstract available


  54. HUANG D, Abbott RK, Havenar-Daughton C, Skog PD, et al
    B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Proc Natl Acad Sci U S A. 2020 Sep 1. pii: 2004489117.
    PubMed     Abstract available


    August 2020
  55. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed     Abstract available


  56. SATHKUMARA HD, Muruganandah V, Cooper MM, Field MA, et al
    Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
    Proc Natl Acad Sci U S A. 2020 Aug 10. pii: 2003235117.
    PubMed     Abstract available


  57. ANTONELLI AC, Binyamin A, Hohl TM, Glickman MS, et al
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-gamma signaling.
    Proc Natl Acad Sci U S A. 2020;117:18627-18637.
    PubMed     Abstract available


  58. PAPADOPOULOU M, Dimova T, Shey M, Briel L, et al
    Fetal public Vgamma9Vdelta2 T cells expand and gain potent cytotoxic functions early after birth.
    Proc Natl Acad Sci U S A. 2020;117:18638-18648.
    PubMed     Abstract available


  59. SPRENGER KG, Louveau JE, Murugan PM, Chakraborty AK, et al
    Optimizing immunization protocols to elicit broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2020 Aug 3. pii: 1919329117.
    PubMed     Abstract available


    July 2020
  60. EYAL N, Lipsitch M
    Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones.
    Proc Natl Acad Sci U S A. 2020 Jul 22. pii: 2014154117.
    PubMed    


  61. VAIDYANATHAN G
    News Feature: Finding a vaccine for misinformation.
    Proc Natl Acad Sci U S A. 2020 Jul 22. pii: 2013249117.
    PubMed    


  62. LIAO HY, Wang SC, Ko YA, Lin KI, et al
    Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Proc Natl Acad Sci U S A. 2020 Jul 15. pii: 2004783117.
    PubMed     Abstract available


  63. ELLEBEDY AH, Nachbagauer R, Jackson KJL, Dai YN, et al
    Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans.
    Proc Natl Acad Sci U S A. 2020 Jul 13. pii: 1906613117.
    PubMed     Abstract available


  64. ESCOBAR LE, Molina-Cruz A, Barillas-Mury C
    BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
    Proc Natl Acad Sci U S A. 2020 Jul 9. pii: 2008410117.
    PubMed     Abstract available


    June 2020
  65. KORN L, Bohm R, Meier NW, Betsch C, et al
    Vaccination as a social contract.
    Proc Natl Acad Sci U S A. 2020 Jun 15. pii: 1919666117.
    PubMed     Abstract available


    May 2020
  66. WELLS CR, Huppert A, Fitzpatrick MC, Pandey A, et al
    Prosocial polio vaccination in Israel.
    Proc Natl Acad Sci U S A. 2020 May 26. pii: 1922746117.
    PubMed     Abstract available


    April 2020
  67. ESSWEIN SR, Gristick HB, Jurado A, Peace A, et al
    Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
    Proc Natl Acad Sci U S A. 2020 Apr 22. pii: 1919269117.
    PubMed     Abstract available


    March 2020
  68. PEEPLES L
    News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 2005456117.
    PubMed    


  69. TIAN M, McGovern K, Cheng HL, Waddicor P, et al
    Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models.
    Proc Natl Acad Sci U S A. 2020 Mar 24. pii: 1921996117.
    PubMed     Abstract available


  70. SUTTER G
    A vital gene for modified vaccinia virus Ankara replication in human cells.
    Proc Natl Acad Sci U S A. 2020 Mar 16. pii: 2001335117.
    PubMed    


  71. WEC AZ, Haslwanter D, Abdiche YN, Shehata L, et al
    Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine.
    Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1921388117.
    PubMed     Abstract available


    February 2020
  72. HLADISH TJ, Pearson CAB, Toh KB, Rojas DP, et al
    Designing effective control of dengue with combined interventions.
    Proc Natl Acad Sci U S A. 2020;117:3319-3325.
    PubMed     Abstract available


  73. PENG C, Moss B
    Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Proc Natl Acad Sci U S A. 2020 Feb 4. pii: 1921098117.
    PubMed     Abstract available


    January 2020
  74. LANGOWSKI MD, Khan FA, Bitzer AA, Genito CJ, et al
    Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform.
    Proc Natl Acad Sci U S A. 2020 Jan 27. pii: 1911792117.
    PubMed     Abstract available


  75. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
    Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Proc Natl Acad Sci U S A. 2020;117:1119-1128.
    PubMed     Abstract available


  76. OZDILEK A, Paschall AV, Dookwah M, Tiemeyer M, et al
    Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens.
    Proc Natl Acad Sci U S A. 2020 Jan 6. pii: 1916131117.
    PubMed     Abstract available


    December 2019
  77. VIRK RK, Jayakumar J, Mendenhall IH, Moorthy M, et al
    Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1916585116.
    PubMed     Abstract available


  78. YU KM, Park SJ, Yu MA, Kim YI, et al
    Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model.
    Proc Natl Acad Sci U S A. 2019 Dec 9. pii: 1914704116.
    PubMed     Abstract available


    November 2019
  79. PAES W, Leonov G, Partridge T, Chikata T, et al
    Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8(+) T cells in HIV-1 infection.
    Proc Natl Acad Sci U S A. 2019 Nov 20. pii: 1911622116.
    PubMed     Abstract available


    October 2019
  80. HOEHN KB, Vander Heiden JA, Zhou JQ, Lunter G, et al
    Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination.
    Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1906020116.
    PubMed     Abstract available



  81. Correction for Sah et al., Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1917260116.
    PubMed    


  82. IRENE C, Fantappie L, Caproni E, Zerbini F, et al
    Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1905112116.
    PubMed     Abstract available


    September 2019
  83. SHAFFER L
    Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific.
    Proc Natl Acad Sci U S A. 2019;116:19214-19217.
    PubMed    


  84. SAH P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, et al
    Future epidemiological and economic impacts of universal influenza vaccines.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1909613116.
    PubMed     Abstract available


  85. NOBIS CC, Dubeau Laramee G, Kervezee L, Maurice De Sousa D, et al
    The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways.
    Proc Natl Acad Sci U S A. 2019 Sep 16. pii: 1905080116.
    PubMed     Abstract available


  86. RASHEED MAU, Hickman CJ, McGrew M, Sowers SB, et al
    Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.
    Proc Natl Acad Sci U S A. 2019 Sep 3. pii: 1905570116.
    PubMed     Abstract available


    August 2019
  87. FELDMAN MF, Mayer Bridwell AE, Scott NE, Vinogradov E, et al
    A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1907833116.
    PubMed     Abstract available


  88. DE LIMA DS, Cardozo LE, Maracaja-Coutinho V, Suhrbier A, et al
    Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination.
    Proc Natl Acad Sci U S A. 2019 Aug 9. pii: 1822046116.
    PubMed     Abstract available


    July 2019
  89. BOOPATHY AV, Mandal A, Kulp DW, Menis S, et al
    Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination.
    Proc Natl Acad Sci U S A. 2019 Jul 29. pii: 1902179116.
    PubMed     Abstract available


  90. ANGELETTI D, Kosik I, Santos JJS, Yewdell WT, et al
    Outflanking immunodominance to target subdominant broadly neutralizing epitopes.
    Proc Natl Acad Sci U S A. 2019;116:13474-13479.
    PubMed     Abstract available


    June 2019
  91. DEERE JD, Chang WLW, Villalobos A, Schmidt KA, et al
    Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Proc Natl Acad Sci U S A. 2019 Jun 12. pii: 1903317116.
    PubMed     Abstract available


    May 2019
  92. LU Y, Stuart JH, Talbot-Cooper C, Agrawal-Singh S, et al
    Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.
    Proc Natl Acad Sci U S A. 2019 May 24. pii: 1816399116.
    PubMed     Abstract available


  93. WANG S, Qin L, Yamankurt G, Skakuj K, et al
    Rational vaccinology with spherical nucleic acids.
    Proc Natl Acad Sci U S A. 2019 May 8. pii: 1902805116.
    PubMed     Abstract available


    April 2019
  94. WELLS CR, Pandey A, Parpia AS, Fitzpatrick MC, et al
    Ebola vaccination in the Democratic Republic of the Congo.
    Proc Natl Acad Sci U S A. 2019 Apr 29. pii: 1817329116.
    PubMed     Abstract available


  95. WEIDENBACHER PA, Kim PS
    Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope.
    Proc Natl Acad Sci U S A. 2019 Apr 26. pii: 1822062116.
    PubMed     Abstract available


    March 2019
  96. STEFANETTI G, Okan N, Fink A, Gardner E, et al
    Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis.
    Proc Natl Acad Sci U S A. 2019 Mar 14. pii: 1900144116.
    PubMed     Abstract available


  97. SHEN L, Frencher J, Huang D, Wang W, et al
    Immunization of Vgamma2Vdelta2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates.
    Proc Natl Acad Sci U S A. 2019 Mar 8. pii: 1811380116.
    PubMed     Abstract available


    February 2019
  98. NEIDEL S, Ren H, Torres AA, Smith GL, et al
    NF-kappaB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-kappaB activation.
    Proc Natl Acad Sci U S A. 2019 Feb 28. pii: 1813504116.
    PubMed     Abstract available


  99. VANARSDALL AL, Chin AL, Liu J, Jardetzky TS, et al
    HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
    Proc Natl Acad Sci U S A. 2019;116:3728-3733.
    PubMed     Abstract available


  100. TSENG YC, Wu CY, Liu ML, Chen TH, et al
    Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1819197116.
    PubMed     Abstract available


    January 2019
  101. MARTINS MA, Bischof GF, Shin YC, Lauer WA, et al
    Vaccine protection against SIVmac239 acquisition.
    Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1814584116.
    PubMed     Abstract available


    December 2018
  102. RAPPUOLI R, De Gregorio E, Costantino P
    On the mechanisms of conjugate vaccines.
    Proc Natl Acad Sci U S A. 2018 Dec 21. pii: 1819612116.
    PubMed    


  103. BLOOM DE, Black S, Salisbury D, Rappuoli R, et al
    Antimicrobial resistance and the role of vaccines.
    Proc Natl Acad Sci U S A. 2018;115:12868-12871.
    PubMed    


  104. SEVILLA JP, Bloom DE, Cadarette D, Jit M, et al
    Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.
    Proc Natl Acad Sci U S A. 2018;115:12911-12919.
    PubMed     Abstract available


  105. KENNEDY DA, Read AF
    Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.
    Proc Natl Acad Sci U S A. 2018;115:12878-12886.
    PubMed     Abstract available


  106. KLUGMAN KP, Black S
    Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.
    Proc Natl Acad Sci U S A. 2018;115:12896-12901.
    PubMed     Abstract available


  107. TEDIJANTO C, Olesen SW, Grad YH, Lipsitch M, et al
    Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora.
    Proc Natl Acad Sci U S A. 2018;115:E11988-E11995.
    PubMed     Abstract available


  108. BAKER SJ, Payne DJ, Rappuoli R, De Gregorio E, et al
    Technologies to address antimicrobial resistance.
    Proc Natl Acad Sci U S A. 2018;115:12887-12895.
    PubMed     Abstract available


  109. KAPLONEK P, Khan N, Reppe K, Schumann B, et al
    Improving vaccines against Streptococcus pneumoniae using synthetic glycans.
    Proc Natl Acad Sci U S A. 2018 Dec 7. pii: 1811862115.
    PubMed     Abstract available


  110. SUN X, Stefanetti G, Berti F, Kasper DL, et al
    Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1816401115.
    PubMed     Abstract available


    November 2018
  111. POGORELYY MV, Minervina AA, Touzel MP, Sycheva AL, et al
    Precise tracking of vaccine-responding T cell clones reveals convergent and personalized response in identical twins.
    Proc Natl Acad Sci U S A. 2018 Nov 20. pii: 1809642115.
    PubMed     Abstract available


  112. FINK AL, Engle K, Ursin RL, Tang WY, et al
    Biological sex affects vaccine efficacy and protection against influenza in mice.
    Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
    PubMed     Abstract available


  113. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
    Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
    PubMed     Abstract available


    September 2018
  114. MICOLI F, Rondini S, Alfini R, Lanzilao L, et al
    Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
    Proc Natl Acad Sci U S A. 2018 Sep 27. pii: 1807655115.
    PubMed     Abstract available


  115. CROFTS AA, Giovanetti SM, Rubin EJ, Poly FM, et al
    Enterotoxigenic E. coli virulence gene regulation in human infections.
    Proc Natl Acad Sci U S A. 2018;115:E8968-E8976.
    PubMed     Abstract available


  116. BOTTERMANN M, Foss S, van Tienen LM, Vaysburd M, et al
    TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 12. pii: 1806314115.
    PubMed     Abstract available


  117. HAABETH OAW, Blake TR, McKinlay CJ, Waymouth RM, et al
    mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.
    Proc Natl Acad Sci U S A. 2018 Sep 10. pii: 1810002115.
    PubMed     Abstract available


  118. PARKS RJ, Gussoni E
    Building immune tolerance through DNA vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 6. pii: 1813461115.
    PubMed    


    August 2018
  119. JURASKA M, Magaret CA, Shao J, Carpp LN, et al
    Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
    Proc Natl Acad Sci U S A. 2018 Aug 20. pii: 1714250115.
    PubMed     Abstract available


    July 2018
  120. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Abstract available


  121. LI W, Zhang X, Yang Y, Yin Q, et al
    Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary Haemophilus influenzae infection.
    Proc Natl Acad Sci U S A. 2018;115:E7149-E7157.
    PubMed     Abstract available



  122. Retraction for Ganesh et al., Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1806429115.
    PubMed    


    June 2018
  123. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Abstract available


  124. SCHLEISS MR
    Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.
    Proc Natl Acad Sci U S A. 2018 Jun 6. pii: 1806420115.
    PubMed    


    May 2018
  125. BRYNILDSRUD OB, Eldholm V, Bohlin J, Uadiale K, et al
    Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Proc Natl Acad Sci U S A. 2018;115:5510-5515.
    PubMed     Abstract available


  126. TZENG SY, McHugh KJ, Behrens AM, Rose S, et al
    Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.
    Proc Natl Acad Sci U S A. 2018 May 21. pii: 1720970115.
    PubMed     Abstract available


    April 2018
  127. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Abstract available


  128. NELSON CS, Huffman T, Jenks JA, Cisneros de la Rosa E, et al
    HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1800177115.
    PubMed     Abstract available


  129. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
    Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
    PubMed     Abstract available


  130. PETTIGREW MM, Ahearn CP, Gent JF, Kong Y, et al
    Haemophilus influenzae genome evolution during persistence in the human airways in chronic obstructive pulmonary disease.
    Proc Natl Acad Sci U S A. 2018;115:E3256-E3265.
    PubMed     Abstract available


  131. STEVENSON TC, Cywes-Bentley C, Moeller TD, Weyant KB, et al
    Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
    Proc Natl Acad Sci U S A. 2018;115:E3106-E3115.
    PubMed     Abstract available


    March 2018
  132. OBOLSKI U, Lourenco J, Thompson C, Thompson R, et al
    Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2018 Mar 6. pii: 1718712115.
    PubMed     Abstract available


    January 2018
  133. VERMA AA, Jimenez MP, Tangermann RH, Subramanian SV, et al
    Insecurity, polio vaccination rates, and polio incidence in northwest Pakistan.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1711923115.
    PubMed     Abstract available


    December 2017
  134. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Abstract available


  135. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Abstract available


  136. PANANOS AD, Bury TM, Wang C, Schonfeld J, et al
    Critical dynamics in population vaccinating behavior.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1704093114.
    PubMed     Abstract available


  137. WEISBERG AS, Maruri-Avidal L, Bisht H, Hansen BT, et al
    Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants.
    Proc Natl Acad Sci U S A. 2017 Dec 4. pii: 1716255114.
    PubMed     Abstract available


    November 2017
  138. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Abstract available


    October 2017
  139. KOEHLER H, Cotsmire S, Langland J, Kibler KV, et al
    Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Proc Natl Acad Sci U S A. 2017;114:11506-11511.
    PubMed     Abstract available


  140. BUSTAMANTE LY, Powell GT, Lin YC, Macklin MD, et al
    Synergistic malaria vaccine combinations identified by systematic antigen screening.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201702944.
    PubMed     Abstract available


  141. LISBOA MP, Khan N, Martin C, Xu FF, et al
    Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5.
    Proc Natl Acad Sci U S A. 2017 Oct 2. pii: 201706875.
    PubMed     Abstract available


    May 2017
  142. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: